Paul F. Lizzul

Differential Expression of Phosphorylated NF-κB/RelA in Normal and Psoriatic Epidermis and Downregulation of NF-κB in Response to Treatment with Etanercept

Paul F. Lizzul, Abhishek Aphale, Rama Malaviya et al. · Journal of Investigative Dermatology · 2005 · 210 citations · Full text

Life Sciences, Dermatology, Immunology +14

REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction

Derek Jones, Jean Carruthers, John Joseph et al. · Dermatologic Surgery · 2015 · 132 citations

Medicine, Pharmacology, Pharmacotherapy +8

ATX-101 for reduction of submental fat: A phase III randomized controlled trial

Shannon Humphrey, Jonathan M. Sykes, Jonathan Kantor et al. · Journal of the American Academy of Dermatology · 2016 · 120 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

Shiu-chung Au, Ari M. Goldminz, Noori Kim et al. · Journal of Dermatological Treatment · 2012 · 67 citations

Medicine, Dermatology, Pharmacotherapy +13

Prevalence of the Metabolic Syndrome in Children with Psoriatic Disease

Ari M. Goldminz, Catherine D. Buzney, Noori Kim et al. · Pediatric Dermatology · 2013 · 65 citations

Medicine, Dermatology, Pediatrics +15